Sign in
4

Changes in Ownership

SpyGlass Pharma, Inc. Filed Acc 0001231919-26-000135

Director bought 3,690,000 shares at $16.00 ($59,040,000)

  • Director acquired 4,331,117 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

RA CAPITAL MANAGEMENT, L.P. · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-09 Conversion : show line 1 in the form +2,524,473 2,524,473 I
2026-02-09 Conversion : show line 2 in the form +1,806,644 1,806,644 I
2026-02-09 Purchase : show line 3 in the form +3,441,966 $16.00 $55,071,456 5,966,439 I
2026-02-09 Purchase : show line 4 in the form +248,034 $16.00 $3,968,544 2,054,678 I
Open-market purchases · 3,690,000 sh · avg $16.00 · $59,040,000

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2026-02-09 Conversion : show line 5 in the form Series C-1 Preferred Stock −1,150,941 0 I
2026-02-09 Conversion : show line 6 in the form Series C-1 Preferred Stock −767,294 0 I
2026-02-09 Conversion : show line 7 in the form Series C-2 Preferred Stock −1,150,941 0 I
2026-02-09 Conversion : show line 8 in the form Series C-2 Preferred Stock −767,294 0 I
2026-02-09 Conversion : show line 9 in the form Series D Preferred Stock −222,591 0 I
2026-02-09 Conversion : show line 10 in the form Series D Preferred Stock −272,056 0 I
Loading xslF345X05/form4-02112026_100217.xml…